Çeşitli böbrek hastalığı olan çocuklarda gentamisinin, N-asetil-beta-D-glukozaminidazın, beta-2 mikroglobulinin, mikroalbuminin ve biyokimyasal parametrelerin değişimlerinin incelenmesi
Study of gentamicin, -acetyl-beta-D- glucosaminidase, beta-2 microglobulin, microalbumin and biochemical parameters changes in different pediatric kidney diseases
- Tez No: 27719
- Danışmanlar: DOÇ. DR. FİKRET VEHBİ İZZETTİN
- Tez Türü: Doktora
- Konular: Biyokimya, Biochemistry
- Anahtar Kelimeler: Albüminüri, Asetilglükozaminidaz, Beta 2 mikroglobülin, Böbrek hastalıkları, Gentamisinler, Albuminuria, Acetylglucosaminidase, Beta 2 microglobulin, Kidney diseases, Gentamicins
- Yıl: 1993
- Dil: Türkçe
- Üniversite: Marmara Üniversitesi
- Enstitü: Sağlık Bilimleri Enstitüsü
- Ana Bilim Dalı: Biyokimya Ana Bilim Dalı
- Bilim Dalı: Belirtilmemiş.
- Sayfa Sayısı: Belirtilmemiş.
Özet
135 VII. SUMMARY STUDY OF GENTAMICIN, N-ACETYL-BETA-D-GLUCOSAMINIDASE, BETA-2 MICROGLOBULIN, MICROALBUMIN AND BIOCHEMICAL PARAMETERS CHANGES IN DIFFERENT PEDIATRIC KIDNEY DISEASES This study was conducted to study the importance of different biochemical parameters, N-acetyl-jS-D-glucosaminidase, beta-2 microglobu lin and microalbumin in early detection and monitoring of patients with different pediatric kidney diseases. Fifty-four pediatric patients with various kidney diseases were followed in this study: 20 patients with Acute glomerulonephritis, 8 pati ents with Nephrotic syndrome, 5 patients with Henoch-Schönlein nephritis and 21 patients with Urinary tract infections. The data indicate N-a- cetyl-/3-D-glucosaminidase and beta-2 microglobulin are good indicators for various kidney diseases compared to biochemical parameters and mic roalbumin. The level of N-acetyl-j3-D-glucosaminidase in urine measured colorimetrically and its level before treatment are significantly higher than control group (1.85±0. 30 U/L; 2.44±0.68 U/g urine creatinine). The urine level of N-acetyl-/J-D-glucosominidase before treatment were as follows (Mean+SD): Acute glomerulonephritis (7.88±6.64 U/L; 14.74±12.00 U/g136 urine creatinine), Nephrotic syndrome (15.51±8.92 U/L; 32.93+22.45 U/g urine creatinine), Henoch-Schönlein nephritis (8.62+2.25 U/L; 24. 94± 13.76 U/g urine creatinine), Urinary tract infection (6.94 + 4.08 U/L; 15.88+13.83 U/g urine creatinine). The urine level of beta-2 microglobulin measured by immunoradi- ometric assay method. The level of beta-2 microglobulin are significantly higher than control group (21.50±4.48 ng/ml, 29.52±6.78 ng/mg urine cre atinine). The urine level of beta-2 microglobulin before treatment were as follows (MeaniSD): Acute glomerulonephritis (54.55+38.06 ng/ml; 110.74±67.82 ng/mg urine creatinine), Nephrotic syndrome (235.00±150.99 ng/ml; 521.47+383.40 ng/mg urine creatinine). Henoch-Sc hönlein nephritis (42.40+8.98 ng/ml; 127.80178.31 ng/mg urine creatini ne), Urinary tract infection (120.23±80.20 ng/ml; 33.71±15.46 ng/mg uri ne creatinine). In this study the level of gentamicin monitored in 21 patients with urinary tract infection treated with gentamicin 5 mg/kg/I.M showed serum level within therapeutic level (2-10 /zg/ml). As a conclusion due to higher stability of N-acetyl-/î-D-glucosa- minidase in urine and absence of diurnal variation of excretion of N-a- cetyl-0-D-glucosaminidase suggest the analysis of N-acetyl-/?-D-glucosami- nidase in determination and following of pediatrics patients with different kidney disease better than beta-2 microglobulin. Also this stuy indicate the importance of monitoring of gentamicin level to prevent nephrotoxicity and ototoxicity in pediatric therapy.
Özet (Çeviri)
135 VII. SUMMARY STUDY OF GENTAMICIN, N-ACETYL-BETA-D-GLUCOSAMINIDASE, BETA-2 MICROGLOBULIN, MICROALBUMIN AND BIOCHEMICAL PARAMETERS CHANGES IN DIFFERENT PEDIATRIC KIDNEY DISEASES This study was conducted to study the importance of different biochemical parameters, N-acetyl-jS-D-glucosaminidase, beta-2 microglobu lin and microalbumin in early detection and monitoring of patients with different pediatric kidney diseases. Fifty-four pediatric patients with various kidney diseases were followed in this study: 20 patients with Acute glomerulonephritis, 8 pati ents with Nephrotic syndrome, 5 patients with Henoch-Schönlein nephritis and 21 patients with Urinary tract infections. The data indicate N-a- cetyl-/3-D-glucosaminidase and beta-2 microglobulin are good indicators for various kidney diseases compared to biochemical parameters and mic roalbumin. The level of N-acetyl-j3-D-glucosaminidase in urine measured colorimetrically and its level before treatment are significantly higher than control group (1.85±0. 30 U/L; 2.44±0.68 U/g urine creatinine). The urine level of N-acetyl-/J-D-glucosominidase before treatment were as follows (Mean+SD): Acute glomerulonephritis (7.88±6.64 U/L; 14.74±12.00 U/g136 urine creatinine), Nephrotic syndrome (15.51±8.92 U/L; 32.93+22.45 U/g urine creatinine), Henoch-Schönlein nephritis (8.62+2.25 U/L; 24. 94± 13.76 U/g urine creatinine), Urinary tract infection (6.94 + 4.08 U/L; 15.88+13.83 U/g urine creatinine). The urine level of beta-2 microglobulin measured by immunoradi- ometric assay method. The level of beta-2 microglobulin are significantly higher than control group (21.50±4.48 ng/ml, 29.52±6.78 ng/mg urine cre atinine). The urine level of beta-2 microglobulin before treatment were as follows (MeaniSD): Acute glomerulonephritis (54.55+38.06 ng/ml; 110.74±67.82 ng/mg urine creatinine), Nephrotic syndrome (235.00±150.99 ng/ml; 521.47+383.40 ng/mg urine creatinine). Henoch-Sc hönlein nephritis (42.40+8.98 ng/ml; 127.80178.31 ng/mg urine creatini ne), Urinary tract infection (120.23±80.20 ng/ml; 33.71±15.46 ng/mg uri ne creatinine). In this study the level of gentamicin monitored in 21 patients with urinary tract infection treated with gentamicin 5 mg/kg/I.M showed serum level within therapeutic level (2-10 /zg/ml). As a conclusion due to higher stability of N-acetyl-/î-D-glucosa- minidase in urine and absence of diurnal variation of excretion of N-a- cetyl-0-D-glucosaminidase suggest the analysis of N-acetyl-/?-D-glucosami- nidase in determination and following of pediatrics patients with different kidney disease better than beta-2 microglobulin. Also this stuy indicate the importance of monitoring of gentamicin level to prevent nephrotoxicity and ototoxicity in pediatric therapy.
Benzer Tezler
- Böbrek hastalıklı ve normal çocuklarda intravenöz amino asit uygulaması ile renal fonksiyonel rezerv testinin değerlendirilmesi
Başlık çevirisi yok
AYSEL KIYAK
Tıpta Uzmanlık
Türkçe
1998
Çocuk Sağlığı ve Hastalıklarıİstanbul ÜniversitesiÇocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
- Diyaliz uygulanan kronik böbrek yetersizlikli çocuklarda uyku iği üzerine klinik çalışma
A Clinical analysis of sleep spindles in children with chronic renal failure undergoing dialysis
AYDAN ANGAY
- Böbrek fonksiyonlarını değerlendirmede 99m Tc-MAG3 (Merkapto asetil triglisin)
Başlık çevirisi yok
HULUSİ ÖZKAYA